DE60130661D1 - Verwendung der 13-cis retinsäure zur behandlung von emphysemen - Google Patents

Verwendung der 13-cis retinsäure zur behandlung von emphysemen

Info

Publication number
DE60130661D1
DE60130661D1 DE60130661T DE60130661T DE60130661D1 DE 60130661 D1 DE60130661 D1 DE 60130661D1 DE 60130661 T DE60130661 T DE 60130661T DE 60130661 T DE60130661 T DE 60130661T DE 60130661 D1 DE60130661 D1 DE 60130661D1
Authority
DE
Germany
Prior art keywords
emphysemes
treatment
retinic acid
cis retinic
cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60130661T
Other languages
English (en)
Other versions
DE60130661T2 (de
Inventor
Paula Nanette Belloni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE60130661D1 publication Critical patent/DE60130661D1/de
Publication of DE60130661T2 publication Critical patent/DE60130661T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60130661T 2000-08-02 2001-07-23 Verwendung der 13-cis retinsäure zur behandlung von emphysemen Expired - Fee Related DE60130661T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/631,151 US6339107B1 (en) 2000-08-02 2000-08-02 Methods for treatment of Emphysema using 13-cis retinoic acid
US631151 2000-08-02
PCT/EP2001/008484 WO2002009679A2 (en) 2000-08-02 2001-07-23 Use of 13-cis retinoic acid for the treatment of emphysema

Publications (2)

Publication Number Publication Date
DE60130661D1 true DE60130661D1 (de) 2007-11-08
DE60130661T2 DE60130661T2 (de) 2008-07-03

Family

ID=24529991

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60130661T Expired - Fee Related DE60130661T2 (de) 2000-08-02 2001-07-23 Verwendung der 13-cis retinsäure zur behandlung von emphysemen

Country Status (7)

Country Link
US (2) US6339107B1 (de)
EP (1) EP1307187B1 (de)
JP (1) JP2004505036A (de)
AU (1) AU2001289726A1 (de)
DE (1) DE60130661T2 (de)
ES (1) ES2292620T3 (de)
WO (1) WO2002009679A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US6339107B1 (en) * 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid
JP2005501810A (ja) * 2001-03-22 2005-01-20 バテル メモリアル インスティチュート ポリマーおよび懸濁粒子を含有する電気流体力学的噴霧用の液体形成物
JP2005507934A (ja) * 2001-10-30 2005-03-24 ネクター セラピューティックス エイエル，コーポレイション レチノイン酸の水溶性ポリマー結合体
US20030185762A1 (en) * 2002-03-22 2003-10-02 Cowan Siu Man L. Highly aqueous liquid carrier formulations
US20040122110A1 (en) * 2002-09-06 2004-06-24 Maccabee Mendy S. Effect of vitamin A gel on paranasal sinus mucosal regeneration
WO2006025395A1 (ja) * 2004-08-31 2006-03-09 Yasuhiko Shimizu キャリアフリーの細胞増殖因子を用いた慢性閉塞性肺疾患に対する医薬および処置システム
WO2006079209A1 (en) * 2005-01-26 2006-08-03 The University Of British Columbia Pulmonary compositions comprising a vitamin a compound and a surfactant and uses thereof
WO2007104030A1 (en) * 2006-03-08 2007-09-13 Kinemed, Inc. Retinoids and related compounds for the treatment of neuroinflammatory conditions, diseases and disorders
US20070254858A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects
US20070254025A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
EP2432553A2 (de) * 2009-05-20 2012-03-28 Ranbaxy Laboratories Limited Flüssige dosierformen von isotretinoin
US10022348B2 (en) 2009-05-20 2018-07-17 Sun Pharmaceutical Industries Limited Topical solution of isotretinoin
CN102458362A (zh) 2009-05-20 2012-05-16 兰贝克赛实验室有限公司 外用类维生素a溶液
BR112015015421A2 (pt) * 2012-12-27 2017-07-11 Microdose Therapeutx Inc métodos e composições para a administração de oxibutinina
EP3348279B1 (de) * 2015-09-10 2021-08-04 National University Corporation Okayama University Medizinische zusammensetzung zur prävention oder behandlung von entzündlichen atemwegserkrankungen
CN113372368B (zh) * 2020-03-09 2022-04-12 苏州爱科百发生物医药技术有限公司 一种弹性蛋白酶抑制剂前药及其用途
WO2023168608A1 (en) * 2022-03-08 2023-09-14 Mastery Biotech Co., Ltd. Pharmaceutical composition including retinoic acid and carbohydrate and use thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB334585A (en) * 1929-06-06 1930-09-08 British Glues And Chemicals Lt Improvements in or relating to the separation of solids from liquids
ZA791659B (en) 1978-04-17 1980-04-30 Ici Ltd Process and apparatus for spraying liquid
GB8504253D0 (en) 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
IL90069A (en) 1988-04-26 1994-04-12 Us Health The use of 31 cysts of retinoic acid in the preparation of a drug for the treatment of congenital conjunctivitis
DE3815221C2 (de) 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
GB9116909D0 (en) * 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
TW272187B (de) 1992-05-20 1996-03-11 Hoffmann La Roche
GB9225098D0 (en) 1992-12-01 1993-01-20 Coffee Ronald A Charged droplet spray mixer
GB9226717D0 (en) 1992-12-22 1993-02-17 Coffee Ronald A Induction-operated electro-hydrodynamic spray device with means of modifying droplet trajectories
GB9406255D0 (en) 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
GB9406171D0 (en) 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
GB9410658D0 (en) 1994-05-27 1994-07-13 Electrosols Ltd Dispensing device
ES2140069T3 (es) 1995-03-14 2000-02-16 Siemens Ag Dispositivo atomizador ultrasonico con unidad dosificadora de precision desmontable.
JP3142577B2 (ja) 1995-03-14 2001-03-07 シーメンス アクチエンゲゼルシヤフト 着脱自在な精密計量供給ユニット
WO1997039745A1 (en) 1996-04-19 1997-10-30 Sloan-Kettering Institute For Cancer Research Use of inhaled retinoids in the prevention of cancer
US6515022B2 (en) * 1996-04-19 2003-02-04 Sloan-Kettering Institute For Cancer Research Use of inhaled retinoids in the treatment of lung diseases
US5998486A (en) 1997-07-08 1999-12-07 Georgetown University School Of Medicine Treatment of emphysema with retinoic acid or other retinoids by inducing formation of gas-exchange units (alveoli)
US5954047A (en) 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
BR9908771A (pt) 1998-03-16 2000-12-12 Inhale Therapeutic Syst Processos para a liberação de um agente ativo e de insulina para os pulmões de um paciente humano, dispositivo para aumentar a biodisponibilidade de um agente ativo, e, dispositivos para a liberação de um agente ativo e de insulina para os pulmões de um paciente humano
US6339107B1 (en) * 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid

Also Published As

Publication number Publication date
DE60130661T2 (de) 2008-07-03
US6794416B2 (en) 2004-09-21
US20020049252A1 (en) 2002-04-25
WO2002009679A2 (en) 2002-02-07
WO2002009679A3 (en) 2002-04-18
EP1307187A2 (de) 2003-05-07
ES2292620T3 (es) 2008-03-16
EP1307187B1 (de) 2007-09-26
US6339107B1 (en) 2002-01-15
AU2001289726A1 (en) 2002-02-13
JP2004505036A (ja) 2004-02-19

Similar Documents

Publication Publication Date Title
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
DE60335560D1 (de) Zusammensetzungen enthaltend zitronensäure zur behandlung von nagelpilzerkrankungen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60025369D1 (de) Unterchlorige säure enthaltendes superoxidiertes wasser zur behandlung von wunden
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60031710D1 (de) Fettsäurederivat zur behandlung von externen sekretionsstörungen
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE279386T1 (de) Retinoide zur behandlung von emphysem
ATE296628T1 (de) Integrinhemmer zur behandlung von augenkrankheiten
ATE254913T1 (de) Diacerein zur behandlung von psoriasis
ATE344661T1 (de) Rar-gamma selektive retinoid-agonisten zur behandlung von emphysemen
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60214355D1 (de) Exemestan zur behandlung von hormonabhängigen störungen
ATE418552T1 (de) Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
DE60026644D1 (de) Verwendung von Ferulasäure zur Behandlung von Bluthochdruck
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee